Immunohistochemistry analysis for MSH6 in the tumor of patient HPC332 showed normal MSH6 expression, thus reducing the likelihood that the MSH6 c.1729C>T variant is a PrCa risk factor and rendering the ATM mutation c.8560C>T the most likely risk variant in this patient. The gene discussed is MSH6; the disease is neoplasm.